Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Axis NIFTY Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited19.2345217233.9788
Domestic EquitiesMax Healthcare Institute Limited8.6124153211.7815
Domestic EquitiesCipla Limited8.5827115941.7754
Domestic EquitiesDivi's Laboratories Limited8.197326181.6957
Domestic EquitiesDr. Reddy's Laboratories Limited7.6420125581.5808
Domestic EquitiesApollo Hospitals Enterprise Limited7.386720831.5280
Domestic EquitiesLupin Limited5.019949871.0384
Domestic EquitiesFortis Healthcare Limited4.7715107390.9870
Domestic EquitiesLaurus Labs Limited3.993180090.8260
Domestic EquitiesTorrent Pharmaceuticals Limited3.877921560.8022
Domestic EquitiesAurobindo Pharma Limited3.421157690.7077
Domestic EquitiesAlkem Laboratories Limited3.174311550.6566
Domestic EquitiesGlenmark Pharmaceuticals Limited2.922331060.6045
Domestic EquitiesMankind Pharma Limited2.530023250.5234
Domestic EquitiesBiocon Limited2.3881124010.4940
Domestic EquitiesZydus Lifesciences Limited2.346551500.4854
Domestic EquitiesIPCA Laboratories Limited2.013328660.4165
Domestic EquitiesAbbott India Limited1.55571070.3218
Domestic EquitiesSyngene International Limited1.224839080.2534
Domestic EquitiesPiramal Pharma Limited1.0639117560.2201
Total 99.9578 20.6770
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.1895 0.0392
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1473 -0.0305
Total 0.0422 0.0087
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.